Fragment-based drug design : tools, practical approaches, and examples /
There are numerous excellent reviews on Fragment Based Drug Discovery (FBDD), but there are to date no hand-holding guides or protocols with which one can embark on this orthogonal approach to complement traditional high throughput screening methodologies. This Methods in Enzymology volume offers th...
Άλλοι συγγραφείς: | |
---|---|
Μορφή: | Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Amsterdam ; Boston, Mass. :
Academic Press,
©2011.
|
Έκδοση: | 1st ed. |
Σειρά: | Methods in enzymology ;
v. 493. |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Designing a diverse high-quality library for crystallography-based FBDD screening
- Preparation of protein samples for NMR structure, function, and small-molecule screening studies
- Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology
- Predicting the success of fragment screening by X-ray crystallography
- Fragment screening of stabilized G-protein-coupled receptors using biophysical methods
- Using computational techniques in fragment-based drug discovery
- How to avoid rediscovering the known
- From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance
- Practical aspects of NMR-based fragment screening
- Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach
- Protein thermal shifts to identify low molecular weight fragments
- HTS reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signature
- Fragment screening purely with protein crystallography
- Computational approach to de novo discovery of fragment binding for novel protein states
- Lead generation and examples opinion regarding how to follow up hits
- Medicinal chemistry inspired fragment-based drug discovery
- Effective progression of nuclear magnetic resonance-detected fragment hits
- Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy
- Electron density guided fragment-based drug design--a lead generation example
- Experiences in fragment-based lead discovery
- Fragment screening of infectious disease targets in a structural genomics environment.